Fesoterodine PR 4 mg
Sponsors
Pfizer
Conditions
Urinary Bladder, Neurogenic
Phase 3
A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition
CompletedNCT01557244
Start: 2012-07-02End: 2020-02-13Updated: 2021-02-02
Open-label Long-term Extension Study of Fesoterodine in Japanese Subjects With Neurogenic Detrusor Overactivity.
CompletedNCT02501928
Start: 2015-06-05End: 2020-04-01Updated: 2020-11-30